[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=aea43645b7854f3374a7c391125267bfd202db8b84412657bb92b53ba9779576",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732120860,
      "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "id": 131531965,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=aea43645b7854f3374a7c391125267bfd202db8b84412657bb92b53ba9779576"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=b0e9e0e4d8d6a0c156f4729eea0b964c9021aff8ab6b89a016fee85e68249999",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732111217,
      "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 131520031,
      "image": "https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=b0e9e0e4d8d6a0c156f4729eea0b964c9021aff8ab6b89a016fee85e68249999"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms",
    "summary": "PRINCETON - Bristol Myers Squibb today announced the presentation of more than 90 data disclosures, including 18 oral presentations, across company-sponsored studies, investigator-sponsored studies...",
    "url": "https://finnhub.io/api/news?id=08b058314b8da0dc624277e78ee6e6853625702dee222c25e924f49319974917",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732100906,
      "headline": "Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms",
      "id": 131504350,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "PRINCETON - Bristol Myers Squibb today announced the presentation of more than 90 data disclosures, including 18 oral presentations, across company-sponsored studies, investigator-sponsored studies...",
      "url": "https://finnhub.io/api/news?id=08b058314b8da0dc624277e78ee6e6853625702dee222c25e924f49319974917"
    }
  },
  {
    "ts": null,
    "headline": "XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)",
    "summary": "We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.",
    "url": "https://finnhub.io/api/news?id=fda1041225add2352abc51ab2126c9563bd38831235bdf55044cf40be42ddef3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732093680,
      "headline": "XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)",
      "id": 131502070,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1496411389/image_1496411389.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.",
      "url": "https://finnhub.io/api/news?id=fda1041225add2352abc51ab2126c9563bd38831235bdf55044cf40be42ddef3"
    }
  }
]